Fever and Right Upper Quadrant Pain After Portal Vein Embolization
A 59-year-old woman with colorectal liver metastases undergoes right portal vein embolization in preparation for right hepatectomy. Baseline future liver remnant (segments II–III) is 22% of total liver volume; the target is ≥25–30%. Embolization is performed with particles and coils; the post-procedure scan shows occlusion of the right portal vein with expected hypoperfusion of the right lobe. On post-procedure day 4 she develops fever to 38.9 °C, right upper quadrant pain, and mild nausea. WBC is 14,200/µL, total bilirubin 1.4 mg/dL (baseline 0.8), and blood cultures are pending. She is hemodynamically stable with a soft abdomen and no peritoneal signs. The surgical team asks whether this is expected post-embolization syndrome or something that requires intervention.
1. How do you distinguish expected post-embolization syndrome from a complication, and what is the immediate management?
Read the worked answer
Post-embolization syndrome (fever, pain, nausea, mild transaminase/bilirubin rise, leukocytosis) is common and typically self-limited, peaking in the first few days. The discriminator is not the presence of fever but the trajectory and the absence of a source.
Favoring expected syndrome here: hemodynamic stability, soft abdomen without peritonitis, fever without rigors, and timing within the first week.
Favoring complication (must exclude):
- Infection/abscess - particularly if there was biliary instrumentation, a stent, or biliary-enteric anastomosis (a classic risk factor for abscess after hepatic embolization). Rigors, rising bilirubin, or persistent fever beyond ~5–7 days should prompt imaging and drainage consideration.
- Portal or hepatic vein thrombosis extending beyond the intended segment.
- Gallbladder ischemia/infarction if cystic artery/portal supply is compromised.
- Liver failure in a marginal remnant.
Immediate management: obtain blood cultures before antibiotics, start broad-spectrum antibiotics given the fever and leukocytosis, provide analgesia and antiemetics, and image (contrast CT) to look for abscess, biliary dilatation, or thrombus extension. Do not reflexively attribute fever to syndrome when there is a biliary risk factor - that is the trap.
2. The CT shows no abscess but the future liver remnant has grown only to 23% at 3 weeks. What are your options and how do you counsel the surgeon?
Read the worked answer
Inadequate hypertrophy after right PVE (23%, below the 25–30% threshold) means the planned resection is not yet safe. Options:
- Wait and reassess - hypertrophy continues for several weeks; repeat volumetry in 2–4 weeks is reasonable if the patient is stable and there is no urgency.
- Extend embolization - if the right portal vein is occluded but segment IV supply persists, additional embolization of segment IV branches can redirect flow to the remnant. This is a recognized salvage maneuver.
- Add hepatic vein deprivation (e.g., right hepatic vein embolization) in selected cases to augment hypertrophy.
- Reconsider the operation - a two-stage hepatectomy or associating liver partition and portal vein ligation (ALPPS) are alternatives, but ALPPS carries substantially higher morbidity and should not be chosen casually in a patient who just had a febrile post-procedure course.
- Reassess resectability and oncologic timing - if the remnant cannot reach an adequate volume, the risk of post-hepatectomy liver failure may outweigh benefit.
Counseling: present the measured volume, the trajectory, and the fact that the recent fever episode should be fully resolved and infection excluded before any further intervention or surgery. The judgement point is that PVE is a means to an end - if the endpoint is not met, the answer is to augment or defer, not to proceed on schedule.